"Peptide YY" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A 36-amino acid peptide produced by the L cells of the distal small intestine and colon. Peptide YY inhibits gastric and pancreatic secretion.
| Descriptor ID |
D019894
|
| MeSH Number(s) |
D06.472.317.662 D06.472.699.595 D12.644.548.595
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Peptide YY".
Below are MeSH descriptors whose meaning is more specific than "Peptide YY".
This graph shows the total number of publications written about "Peptide YY" by people in this website by year, and whether "Peptide YY" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 0 | 1 | 1 |
| 2000 | 0 | 1 | 1 |
| 2001 | 0 | 1 | 1 |
| 2005 | 1 | 1 | 2 |
| 2006 | 1 | 0 | 1 |
| 2008 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2013 | 0 | 1 | 1 |
| 2015 | 0 | 1 | 1 |
| 2020 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Peptide YY" by people in Profiles.
-
Metformin improves blood glucose by increasing incretins independent of changes in gluconeogenesis in youth with type 2 diabetes. Diabetologia. 2020 10; 63(10):2194-2204.
-
Metabolic hormones and breast cancer risk among Mexican American Women in the Mano a Mano Cohort Study. Sci Rep. 2019 07 10; 9(1):9989.
-
Energetic adaptations persist after bariatric surgery in severely obese adolescents. Obesity (Silver Spring). 2015 Mar; 23(3):591-601.
-
LX4211 increases serum glucagon-like peptide 1 and peptide YY levels by reducing sodium/glucose cotransporter 1 (SGLT1)-mediated absorption of intestinal glucose. J Pharmacol Exp Ther. 2013 May; 345(2):250-9.
-
Beneficial effects of a higher-protein breakfast on the appetitive, hormonal, and neural signals controlling energy intake regulation in overweight/obese, "breakfast-skipping," late-adolescent girls. Am J Clin Nutr. 2013 Apr; 97(4):677-88.
-
LX4211, a dual SGLT1/SGLT2 inhibitor, improved glycemic control in patients with type 2 diabetes in a randomized, placebo-controlled trial. Clin Pharmacol Ther. 2012 Aug; 92(2):158-69.
-
Structural dynamics of neuropeptide hPYY. Biopolymers. 2011 Jul; 95(7):487-502.
-
Effects of the gut microbiota on host adiposity are modulated by the short-chain fatty-acid binding G protein-coupled receptor, Gpr41. Proc Natl Acad Sci U S A. 2008 Oct 28; 105(43):16767-72.
-
Ghrelin and peptide YY in youth: are there race-related differences? J Clin Endocrinol Metab. 2006 Aug; 91(8):3117-22.
-
PYY3-36 as an anti-obesity drug target. Obes Rev. 2005 Nov; 6(4):307-22.